Micafungin Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-729

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Micafungin (NDC 63323-729). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Mic17 0000 01)

FDA Label Image

Fresenius Kabi (Mic17 0000 02)

FDA Label Image

Principal Display Panel – Micafungin For Injection 50 mg – Vial Label (Mic17 0000 03)

Principal Display Panel – Micafungin For Injection 50 mg – Vial Label (Mic17 0000 03)
This appears to be the label of a vial of Micafungin for Injection, with a strength of 50mg per vial. The label provides information on the storage condition, dosage, and reconstitution instructions. It also includes a barcode along with batch details and a product code.*
FDA Label Image

Principal Display Panel – Micafungin For Injection 50 mg – Individual Carton (Mic17 0000 04)

Principal Display Panel – Micafungin For Injection 50 mg – Individual Carton (Mic17 0000 04)
Micafungin for Injection is a single dose vial used for intravenous infusion. The package contains instructions for dosage, reconstitution, and administration. The drug must be stored at 25°C with excursions permitted between 15°C and 30°C. It is essential to protect it from light. This drug is preservative-free, and the unused portion must be discarded. The product is manufactured by Fresenius Kabi and can be found under the NDC code 63323-728-01. No other useful information can be obtained from the text.*
FDA Label Image

Principal Display Panel – Micafungin For Injection 50 mg – Shelf Carton (Mic17 0000 05)

Principal Display Panel – Micafungin For Injection 50 mg – Shelf Carton (Mic17 0000 05)
Micafungin for Injection is a medication that comes in single-dose vials each containing 50mg of the drug. It is meant for intravenous infusion and any unused portion should be discarded. This medication is produced by Fresenius Kabi.*
FDA Label Image

Principal Display Panel – Micafungin For Injection 100 mg – Vial Label (Mic17 0000 06)

Principal Display Panel – Micafungin For Injection 100 mg – Vial Label (Mic17 0000 06)
This is a medication with the NDC code 63222-729-01, stored at 25°C to 30°C, with dosage, reconstitution instructions, and dilution recommendations available in the package insert. It is preservative-free and only suitable for intravenous infusion. The medication comes in a vial that contains 100 mg of a substance with a long chemical name. The text includes instructions to protect the medication from light and discard any unused portion. The font is not available.*
FDA Label Image

Principal Display Panel – Micafungin For Injection 100 mg – Individual Carton (Mic17 0000 07)

Principal Display Panel – Micafungin For Injection 100 mg – Individual Carton (Mic17 0000 07)
Micafungin is a medication for injection with a strength of 100 mg per vial. It is recommended to store the medicine at 25°C and discard any unused portion. The medication is intended for intravenous infusion only and is preservative free. The dosage, reconstitution, and dilution instructions can be found in the package. The output also contains various numerical and alphabetic codes that cannot be interpreted as text descriptions.*
FDA Label Image

Principal Display Panel – Micafungin For Injection 100 mg – Shelf Carton (Mic17 0000 08)

Principal Display Panel – Micafungin For Injection 100 mg – Shelf Carton (Mic17 0000 08)
Micafungin for Injection is a medication administered through intravenous infusion, and comes in single doses of 100mg vials. The medication should be discarded if any portion is unused.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.